Nemluvio (Nemolizumab-ilto
- Medicine Name: Nemluvio
- API: Nemolizumab-ilto
- Dosage Form & Strength: Injection: 30 mg solution
- Manufactured By: Galderma Laboratories LP
Nemluvio (nemolizumab-ilto) is an interleukin-31 receptor antagonist used for treating adults with prurigo nodularis, a chronic skin condition characterized by itchy nodules. By blocking IL-31 signaling, the medicine effectively reduces inflammation and itch, offering relief to patients with severe prurigo nodularis.
Recommended Dosage:
Adult Patients Weighing Less Than 90 kg: The recommended dosage for adult patients weighing less than 90 kg is an initial dose of 60 mg (two 30 mg injections), administered subcutaneously, followed by 30 mg given every 4 weeks (Q4W).
Adult Patients Weighing 90 kg or More: The recommended dosage for adult patients weighing 90 kg or more is an initial dose of 60 mg (two 30 mg injections), administered subcutaneously, followed by 60 mg given every 4 weeks (Q4W).
In the event of a missed dose, take the medication as soon as you remember. Afterward, continue with regular dosing at the scheduled time. This ensures proper medication management and helps maintain the effectiveness of your treatment plan.
- Patients may experience hypersensitivity reactions to nemolizumab-ilto 30 mg, including rash, itching, and anaphylaxis. Discontinue usage if any severe allergic reactions occur. Consult your healthcare provider immediately. It is essential to inform your doctor of any prior allergies before starting treatment.
- Treatment with this therapeutic drug may weaken your immune system, potentially affecting the efficacy of vaccinations. It is advised to avoid live vaccines during treatment. Consult your doctor about necessary vaccines before starting therapy to prevent any complications throughout the treatment.
- The safety of treatment with nemolizumab-ilto 30 mg injection during pregnancy has not been established. Pregnant women should only use the medication if necessary and after consulting a healthcare provider. It is crucial to weigh potential risks to the fetus against benefits.
- It is unknown whether nemolizumab-ilto injection is excreted in human milk. Mothers should weigh the benefits of breastfeeding against the potential risks of treatment. Consult your healthcare provider before breastfeeding while on treatment to ensure the safety of your infant.
What documents are required to import NEMLUVIO to India?
NEMLUVIO (nemolizumab-ilto) for injection can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patient ID proof (issued by the government of India)
The order will be confirmed only after the receipt of:
- A valid prescription from the Doctor
- Import permit if applicable
NEMLUVIO (nemolizumab injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Nemluvio in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
IPN (Indian Pharma Network) can facilitate the supply of NEMLUVIO (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Nemluvio 30 mg injection price in India.
We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network can source the NEMLUVIO (Cancer Treatment Medicines) from across the globe and can supply it. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Nemluvio®?
Nemolizumab-ilto is a Generic Name for the trade name drug Nemluvio®.
What is the Manufacturer’s Name of Nemluvio®?
Nemluvio® is manufactured by Galderma Laboratories LP.
Is Nemluvio® approved by the FDA?
Yes, Nemluvio® is approved by the FDA. Date of first approval: August 12, 2024.
What is the dosage and form of Nemluvio® supplied?
Nemluvio® is supplied for injection: single-dose prefilled dual chamber pen containing 30 mg of nemolizumab-ilto lyophilized powder and diluent, water for injection, for subcutaneous use.
What are the most common side effects of Nemluvio®?
The most common side effects of Nemluvio® are headache, eczema, dermatitis atopic, and eczema nummular.
How much does Nemluvio® 30 mg injection cost in India?
Prices may fluctuate over time due to market dynamics and regulatory changes. To obtain accurate and up-to-date information on Nemluvio 30 mg injection cost in India, it is recommended that you Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
Can Nemluvio® 30 mg injections be available in SAARC countries?
Apart from Gulf countries, Nemluvio® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the supply of Nemluvio® injections in these countries, ensuring access to this therapeutic drug through legal and reliable channels.
Is it safe to buy Nemluvio® 30 mg injections online in India?
Yes, one can buy Nemluvio injections 30 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Nemluvio® injections through legal channels.
What are the storage conditions of Nemluvio® injections?
Ensure proper storage of the Nemluvio dual chamber prefilled pen in a refrigerator at 36°F to 46°F (2°C to 8°C). Protect from light by keeping it in its carton. Avoid freezing or sunlight exposure
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.